NON-SMALL CELL LUNG CARCINOMA

This early-phase study is testing the safety of combining a new cancer vaccine with an existing immunotherapy drug (pembrolizumab) in patients with advanced solid tumors that have spread and stopped responding to standard treatments. The vaccine is designed to train the immune sy…

This study is testing whether adding very high doses of vitamin C (given through an IV) to standard chemotherapy and radiation treatment helps people with non-small cell lung cancer. All 43 participants will receive the vitamin C infusion along with their usual cancer therapy. Re…

This study is testing whether adding acupuncture to standard immunotherapy and chemotherapy helps people with advanced non-small cell lung cancer. Sixty participants will be randomly assigned to receive either real acupuncture or a sham (fake) acupuncture treatment during their f…

This was a special access program for the drug capmatinib. It was designed for patients with a specific, advanced form of non-small cell lung cancer who had no other treatment options and could not join a standard clinical trial. The program provided the drug outside of a trial s…

This study is testing a new personalized vaccine treatment for people who have had surgery for non-small cell lung cancer. The goal is to see if the vaccine, given with an immune-boosting drug, can train the body's immune system to recognize and attack any remaining cancer cells …

This study is testing new drug combinations for people with advanced solid tumors that have a specific genetic change called KRAS G12C. It focuses on patients with non-small cell lung cancer or colorectal cancer who have already tried standard treatments. The main goals are to fi…

This study is testing a new combination of two cancer drugs, trastuzumab deruxtecan and pembrolizumab, for people with advanced breast or lung cancer. The first part aims to find a safe dose, and the second part will see how well the combination works to control the cancer. It is…

This study is testing an online support program designed to help women with lung cancer feel better emotionally and manage their symptoms. Participants are assigned to either a group learning mindfulness and coping skills or a group receiving educational information about lung ca…

This study aims to learn how tracking cancer DNA in the blood relates to treatment response. It will observe 102 adults with lung, colorectal, or pancreatic cancer who are receiving standard care. Researchers will collect blood samples over time to see if changes in cancer DNA le…